The Role of New Viral Biomarkers in Chronic Hepatitis B: Ready to Use in the Clinical Practice?


Creative Commons License

Yapali S.

VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL, vol.24, no.2, pp.57-60, 2018 (Journal Indexed in ESCI) identifier

  • Publication Type: Article / Review
  • Volume: 24 Issue: 2
  • Publication Date: 2018
  • Doi Number: 10.4274/vhd.2018.0012
  • Title of Journal : VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL
  • Page Numbers: pp.57-60

Abstract

Recent advances have been made to develop and improve the serologic and molecular virologic tools for the diagnosis and optimal management of chronic hepatitis B (CHB) infection. Several biomarkers associated with the natural course of chronic hepatitis B infection virus (HBV) and the efficacy of antiviral treatment have been defined. This article reviews the impact of hepatitis B surface antigen, hepatitis B core-related antigen and HBV RNA on the natural history, treatment response and outcomes of CHB infection.